维普中文期刊产品整合服务
312篇 您的检索式:作者名="YARDLEY"
    题名 作者 年代 出处 被引量
1在血压控制不良的高血压患者中使用数字化干预的家庭和在线血压管理:随机对照试验显示文摘HOME BP试验(The home and online management and evaluation of blood pressure)的目的是评估在初级预防中结合自我监测和自我管理的数字化干预在高血压管理中的作用。研究者纳入英国76个治疗中心经过治疗但血压控制不好(>140/90 mm Hg, 1 mm Hg=0.133 kPa)并能上网的患者622例,进行自动确定主要终点的公开随机对照试验。McMa-nus RJ Little P Stuart B Morton K Raftery J Kelly J Bradbury K Zhang J Zhu S Murray E May CR Mair FS Michie S Smith P Band R Ogburn E AllenJ Rice C Nut-tall J Williams B Yardley L 陈嘉睿(译) 叶鹏(审校) 2021中华高血压杂志2021,29,5:15
2Classification and Grading of Gastritis: The Updated Sydney System显示文摘Michael F. Dixon Robert M. Genta John H. Yardley Pelayo Correa 1996The American Journal of Surgical Pathology1996,,10:8
3Importance of physical capacity and the effects of exercise in heart transplant recipients显示文摘One of the most important prognostic factors in heart failure patients is physical capacity. Patients with very poor physical performance and otherwise eligible, may be listed as candidates for heart transplantation(HTx). After such surgery, life-long immunosuppression therapy is needed to prevent rejection of the new heart. The dark side of immunosuppression is the increased risk of infections, kidney failure, cancer and advanced atherosclerosis(cardiac allograft vasculopathy), with the two latter conditions as the main causes of later mortality. In a worldwide perspective, 50% of the HTx patients survive past 10 years. Poor aerobic capacity prior to graft deterioration is not only limited to the failing heart, but also caused by peripheral factors, such as limited function in the skeletal muscles and in the blood vessels walls. Exercise rehabilitation after HTx is of major importance in order to improve physical capacity and prognosis. Effects of high-intensity interval training(HIT) in HTx recipients is a growing field of research attracting worldwide focus and interest. Accumulating evidence has shown that HIT is safe and efficient in maintenance HTx recipients; with superior effects on physical capacity compared to conventional moderate exercise. This article generates further evidence to the field by summarizing results from a decade of research performed at our center supported by a broad, but not strict formal, literature review. In short, this article demonstrates a strong association between physical capacity measured after HTx and long-term survival. It describes the possible 'HITeffect' with increased levels of inflammatory mediators of angiogenesis. It also describes long-term effects of HIT; showing a positive effect in development of anxiety symptoms despite that the improved physical capacity was not sustained, due to downregulation ofexercise and intensity. Finally, our results are linked to the ongoing HITTS study, which investigates safety and efficiency of HIT in de novo HTx recipients. Together with previous results, this study may have the potential to change existing guidelines and contribute to a better prognosis for the HTx population as a whole.Marianne Yardley Lars Gullestad Kari Nytr?en 2018World Journal of Transplantation2018,8,1:6
4nab -Paclitaxel mechanisms of action and delivery显示文摘Denise A. Yardley 2013Journal of Controlled Release2013,,3:3
5Developing and Testing an Integrative Model of the Work–Family Interface显示文摘Michael R. Frone John K. Yardley Karen S. Markel 1997Journal of Vocational Behavior1997,,2:2
6Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula显示文摘Kevin J. Kelly Audrey J. Lazenby Peter C. Rowe John H. Yardley Jay A. Perman Hugh A. Sampson 1995Gastroenterology1995,,:2
7Phase H study of neoadjuvant weekly nab-paelitaxel and carboplatin, with bevaci- zumab and trastuzumab, as treatment for women with locally ad- vanced HER2 + breast cancer显示文摘Yardley DA Raefsky E Castillo R 2011Clin Breast Cancer2011,11,5:1
8Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness 显示文摘Yardley L Donovan-Hall M Smith HE 2004Ann Intern Med2004,141,8:1
9Updates in the treatment of basal/triplenegative breast cancer显示文摘Shastry M Yardley DA 2013Cur Opin Obst Gyne2013,25,1:1
10Particulate matter at a rural location in southern England during 2006: Model sensitivities to precursor emissions显示文摘Richard Derwent Claire Witham Alison Redington Michael Jenkin John Stedman Rachel Yardley Garry Hayman 2008Atmospheric Environment2008,,3:1
11Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes显示文摘Yardley DA 2008Clin Breast Cancer2008,8,6:1
12Weekly doeetaxel in the treatment of elderly patients with advanced breast cancer 显示文摘Hainsworth JD Burris HA 3rd Yardley DA 2001J Clin Oncol2001,19,15:1
13Lipid compositions of cells isolated from pig, human, and rat epidennis显示文摘Gray GM Yardley HJ 1975J Lipid Res1975,16,6:1
14A phase lI trial of gemcitabine/carboplatin with or without trastuzumab in the first- line treatment of patients with metastatic breast cancer显示文摘Yardley DA Burris HA 3rd Simons L 2008Clin Breast Cancer2008,8,5:1
15Lateral transfer:A source of additional overpressure? 显示文摘Yardley G S Swarbrick R E 2000Marine and Petroleum Geology2000,17,:1
16Lipid compositions of cells isolated from pig,human, and rat epidermis 显示文摘Gray G M Yardley H G 1975J Lipid Res1975,16,5:1
17Validation of the Falls Efficacy Scale and Falls Efficacy Scale International in geriatric patients with and without cognitive impairment : results of self - report and interview - based questionnaires 显示文摘Hauer K Yardley L Beyer N 2009Gerontology2009,56,2:1
18Cellular adaptaiion to repeated eccentric exercise-induced muscle damage显示文摘STUPKA N TARNOPOLSKY M A YARDLEY N J 2001J Appl Physiol2001,91,4:1
19Regist HER: patient characteristics and time course of CNS metastases in patients with HER2-positive metastatic breast cancer显示文摘Yardley DA Kaufman PA Mayer M 2007Breast Cancer Res Treat2007,106,26:1
20Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis显示文摘Yardley DA Noguchi S Pritchard KI 2013Adv Ther2013,30,10:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费